2022 U.S.-Booked Air Volume: $32.4M
Preferred Air Suppliers: American, British Airways, Delta, United
Preferred Hotel Suppliers: Accor, IHG, Hilton, Hyatt, Marriott
Preferred Car Rental Suppliers: Enterprise
Global Online Booking Tool: Concur
Global Expense Tool: Concur
Global Risk Management Supplier: ISOS
Global Payment Supplier: American Express
Global Consolidated TMC: Amex GBT

2022 was a year of big changes at pharmaceutical giant GSK, with a new moniker—a shortening of its former name, GlaxoSmithKline—and the spinoff of its consumer business, which now operates independently as Haleon. As such, a primary focus of the travel team last year was making sure employees were secure with their card, travel and meeting programs from the onset of the new company set-up.

At the same time, GSK focused on return to travel in 2022, with $32.4 million in U.S.-booked air volume, compared with just $3.5 million in 2021. U.S.-booked air volume this year is projected to increase by more than $3 million over last year, and the company expects, transaction-wise, it will return to pre-pandemic levels within the next few years. Cost-wise, that will happen more quickly due to rising prices from travel suppliers.

GSK also removed the approval process required for C-level employees with international travel in 2022, which was instituted during the Covid-19 pandemic. It is conducting a full review of its travel policy this year.

The company supports "performance by choice," in which employees can work, where possible, in a hybrid set-up.

GSK reported a group turnover of £29.3 billion in 2022, up from £24.7 billion in 2021. As of 2022, GSK had 69,400 employees with operations in more than 80 countries worldwide, including 37 manufacturing sites and four global research and development centers.